The signaling pathways that arrest the cell cycle and trigger cell death are only partially known. Dimerization of CD38, a 45-kD transmembrane type II glycoprotein highly expressed in immature B cells, inhibits cell growth and causes apoptosis in normal and leukemic B-cell progenitors, but the molecular mechanisms underlying these cellular responses are unknown. In the present study, we found that CD38 ligation in the immature B-cell lines 380, REH, and RS4;ll caused rapid tyrosine phosphorylation of the protein product of the proto-oncogene c-cbl. Dimerization of CD38 was accompanied by the association of cb/ with the p85 subunit of phosphatidylinositol 3-kinase (PI 3-K), resulting in markedly increased PI 3-K activity in antiphosphotyrosine and anti-cbl immunoprecipitates. Wortmannin and LY294002, D38 IS A 45-kD transmembrane glycoprotein with the C N-terminus in its short cytoplasmic domain.',' CD38 is expressed by many cell types, including lymphoid progenitors and activated lymphocyte^.^.^ CD38 ligation has stimulatory effects on mature lymphocytes,h but inhibits cell growth and induces apoptosis in B-cell precursor^.^ The molecular mechanisms underlying CD38-mediated growth suppression are still unclear. The structural homology between CD38 and adenosine-diphosphate ribosyl (ADPR)-cyclase had suggested that the function of CD38 might be related to the production of cyclic ADPR, a calcium-mobilizing agent.8 However, CD38 appears to exert its inhibitory effects independently of its enzymatic activity in B-lymphoid progenit o r~.~ We previously found that CD38 ligation with specific antibodies in immature B cells initiates protein tyrosine kinase activity, which results in the rapid and transient tyrosine phosphorylation of several intracellular subtrates, including syk and PLC-Y.~ CD38 dimerization also promotes the association of tyrosine-phosphorylated proteins with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-K),' a lipid kinase that phosphorylates phosphatidylinositols on the D3 position of the inositol ring, and appears to regulate diverse cellular functions such as proliferation, differentiation, and apopto~is.'~-'~ However, other substrates of CD38- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. 0 1996 by The American Society of Hematology. 0006-4971/96/8802-0O9$3.00/0 two potent inhibitors of PI 3-K, rescued immature B cells from CD38-mediated growth suppression. This effect was observed not only in model B a l l lines, but also in cultures of leukemic lymphoblasts from patients, and in normal bone marrow B-cell progenitors as well. Concentrations of inhibitors that reversed cellular responses t o CD38 significantly decreased PI 3-K activity. By contrast, rapamycin, a p70 S6-kinase inhibitor, did not rescue immature B cells from CD38-mediated suppression. These results suggest that PI 3-K activity is essential for CD38-mediated inhibition of lymphopoiesis and that cbl and PI 3-K are regulatory molecules whose activation can result in suppression of cell proliferation and apoptosis in immature lymphoid cells.
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induced protein tyrosine kinase activity, including a prominent 120-kD tyrosine-phosphorylated protein, remained to be identified. In addition, the link between biochemical events and cellular responses triggered by CD38 dimerization had not been proven.
In the present study, we further investigated the signaling pathways used by CD38 and attempted to establish a causeand-effect relationship between the biochemical and cellular consequences of CD38 ligation. We first identified the 120-kD protein phosphorylated after CD38 ligation as cbl, a proto-oncogene product that, in mature lymphoid cells, is phosphorylated after engagement of the B-and T-cell antigen receptor^.'^,'^ Second, we observed that CD38-mediated phosphorylation of cbl is accompanied by its association with PI 3-K. Third, we found that selective inhibitors of mammalian PI 3-K activity, such as wortmannin and LY294002, rescued normal and leukemic immature B lymphoid cells from CD38-mediated growth suppression.
SIGNALING PATHWAYS OF CD38-MEDIATED B-CELL GROWTH SUPPRESSION

591
in RPMI-1640 (Whittaker Bioproducts Inc, Walkersville, MD) with 10% fetal calf serum (FCS; Whittaker), L-glutamine, and antibiotics.
Bone marrow samples were taken, with informed consent from the patients and Institutional Review Board approval, from four healthy bone marrow transplant donors (12 to 24 years of age; median, 14 years) and from five patients with newly diagnosed Blineage acute lymphoblastic leukemia (ALL; 3 to 15 years of age; median, 6 years). In each case of ALL, greater than 80% of the blasts were positive for CD19, CD22, CD38, terminal deoxynucleotidyl transferase, and class I1 antigens and negative for surface Ig. Mononucleated cells were washed three times in PBS and once in AIM-V medium (GIBCO, Grand Island, NY). Normal CD19+ bone marrow cells were purified by use of CD19-immunomagnetic beads (Dynal, Oslo, Norway). Cells were detached from the beads using a goat antiserum to mouse Ig Fab (DETACHaBEAD; Dynal). T cells were removed from suspensions of leukemic lymphoblasts by using a mixture of magnetic beads conjugated to CD4 and CD8 antibodies (Dynal). Cell sorting procedures yielded 90% to 99% pure CD19' cells. The cells' viability consistently exceeded 90% by trypan-blue dye exclusion.
To obtain bone marrow stromal cells, we collected mononucleated cells from normal marrow donors. The cells were separated as described above and washed three times in RPMI-1640. Stromal layers were prepared in flat-bottomed 96-well plates (Costar, Cambridge, MA) and fed with RPMI-1640,10% FCS, and mol& hydrocortisone, as previously de~cribed.'~''~'~ Before each experiment, we removed the media from cultured stromal cells and washed the adherent cells seven times with RPMI-I640 to fully remove hydrocortisone. Leukemic and normal B cells were resuspended in serumfree AIM-V medium and cell lines were resuspended in RPMI-1640 + 10% FCS. Two hundred microliters of the cell suspension (0.1 to 1.5 cells X 106/mL) were then seeded onto marrow stromal cells.
In cultures with wortmannin, LY294002, or rapamycin, control wells were prepared with their diluent DMSO at the maximum concentration used (0.05%). DMSO at this concentration had no discernible effect on cell growth. All cell cultures were incubated at 37°C in 5% C 0 2 with 90% humidity. At the termination of cultures, cells were harvested by vigorous pipetting, suspended in PBS, and passed through a 19-gauge needle to disrupt clumps. Microscopic examination of the plates ensured that all cells in the wells (ie, adherent and nonadherent) were recovered. Viable cells in culture were enumerated by flow cytometry, as previously d e~c r i b e d .~. '~. '~ Immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and Western blotting. Immunoprecipitation was performed essentially as described in Silvennoinen et Briefly, after exposure to anti-CD38 antibody or control Ig, cells were lysed for 20 minutes in 1 mL of ice-cold lysis buffer (50 mmoV L Tris [pH 7.51, 150 mmoVL NaCI, 1% [voUvol] Triton X-100, 5 pglmL aprotinin, 1 mmoVL phenylmethylsulfonyl fluoride, 1 mmoV L EDTA, and 1 mmoVL Na3V04) and centrifuged at 20,OOOg for 20 minutes at 4°C. Supernatants were precleared with 1 hour of protein-A-Sepharose treatment (20 pL of 50% slurry). Antibodies were then added to the cleared lysates, which were incubated at 4°C for 1 to 2 hours. The immune complexes were collected by using protein A-Sepharose. In some experiments, supernatants precleared with anti-cbl and protein A-Sepharose were used instead of the immunoprecipitates.
For SDS-PAGE, immunoprecipitates were resuspended in Laemmli's sample buffer (10% [voUvol] For reprobing, the filters were stripped and then reblocked, washed, and r e p r~b e d .~ All experiments were repeated at least three times. PI 3-K activity was assessed as described by Whitman et al," with some modifications? Briefly, the immunoprecipitates were incubated for 15 minutes at 30°C in 50 pL of 20 mmoVL Tris, pH 7.5, 100 m o l & NaCI, 5 m o V L magnesium chloride, 0.5 mmoVL EGTA, 0.5 mmoVL p-nitrophenylphosphate, 0.2 mmoVL adenosine, 0.5 mg/mL L-a-phosphatidylinositol, 0.5 mg/mL L-a-phosphatidylserine, and 50 pmoVL ATP containing 2 pCi of [y-'*P]ATP. Phospholipids were separated by thin-layer chromatography and autoradiographed. The radioactivity of phospholipids was quantitated by PhosphorImager (Molecular Dynamics, Sunnyvale, CA) with ImageQuant software. All experiments were repeated at least three times. PI 3-K assay.
RESULTS
CD38
-mediated tyrosine phosphorylation of cbl and its association with PI 3-K p85. CD38 ligation in immature B cells induces tyrosine phosphorylation of several proteins, including a prominent one with a mass of approximately 120 kD.9 A protein of similar molecular mass, phosphorylated after cross-linking of B-and T-cell antigen receptors, has recently been identified as the protein product of the protooncogene c -~b l . '~, '~ To determine whether the 120-kD protein phosphorylated by CD38 dimerization corresponded to cbl, we ligated CD38 with the MoAb T16 in the immature B-cell line RS4; 11 and assessed tyrosine phosphorylation in Western blots after removing the cbl protein from the cell lysates with a anti-cbl antibody. This procedure caused a marked decrease in the 120-kD band, without differences in the appearance of the remaining proteins tyrosine phosphorylated after CD38 ligation (Fig l) . To confirm that cbl participated in the CD38-mediated signaling, we directly examined cbl tyrosine phosphorylation in three immature B-cell lines, 380, REH, and RS4; 11. Exposure to anti-CD38, but not to isotype-matched control antibody, caused marked tyrosine phosphorylation of cbl in the three lines (Fig 2) .
Previous studies had shown that cbl can associate with several other intracellular molecules after phosphorylaIn both B and T cells, for example, engagement of the antigen receptor induces an association between cbl and the p85 subunit of PI 3-K.'4.2'.23.24 To assess whether CD38 ligation in immature B cells that lack sIg induced PI 3-K association with cbl, we determined whether PI 3-K was present in the cbl immunoprecipitates obtained from 380, REH, and RS4; 11 cells exposed to anti-CD38 using an anti-PI 3-K p85 antibody. In all three lines, the amount of PI 3-K p85 that coprecipitated with cbl markedly increased after CD38 ligation (Fig 2) . These results indicate that CD38 dimerization causes tyrosine phosphorylation of cbl and its association with PI 3-K p85.
We found previously that CD38 dimerization causes association of PI 3-K p85 with other tyrosine phosphorylated proteins in the RS4; 11 and 380 immature B-cell lines.' As expected, CD38 tion.14,15,2021 PI 3-K activity afer CD38 ligation. an ti-pTyr ant i-C bl ligation in 380, REH. and RS4; 1 I cells also caused a striking increase of PI 3-K activity in antiphosphotyrosine immunoprecipitates ( Fig 3A) . whereas no increase was detected when an isotype-matched nonreactive antibody was used instead. The increase in precipitable PI 3-K activity was detectable after 1 minute of CD38 ligation and appeared to reach maximal levels within 5 minutes, decreasing to less than 50% of maximum within 30 minutes of exposure to anti-CD38 (Fig 3B) . The observed production of phospholipids was most likely due to specific PI 3-K activity in the immunoprecipitates. because the assays were performed in the presence of 0.2 mmol/L adenosine, which inhibits PI 4-kina~e.'~ Moreover. the production of phospholipids was completely inhibited by the addition of 0.1% Triton X-100 or 100 nmol/L wortmannin into the reaction mixture (data not shown), conditions that inhibit PI 3-K but not PI 4-K.'X-" ' The association between chl and PI 3-K p85 induced by CD38 ligation implied that this might be accompanied by increased PI 3-K activity in the chl-p85 complexes. A marked increase in PI 3-K activity was indeed detected in the chl immunoprecipitates from 380, REH, and RS4: 1 I cells exposed to anti-CD38 (Fig 4) .
Ligation of CD38 also increased PI 3-K activity in immunoprecipitates obtained with anti-PI 3-K p85 antibody, although 
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REH RS4:ll . . the increase was significantly lower than that observed in immunoprecipitates obtained with antiphosphotyrosine or anti-chl antibodies. After exposure of 380 cells to anti-CD38. PI 3-K activity increased by 30% to 70% in anti-p8S immunoprecipitates, as compared with the 1.500% increase seen in anti-chl and the 2,200% increase seen in antiphosphotyrosine immunoprecipitates. Taken together, these data indicate that dimerization of CD38 activates PI 3-K activity and strongly promotes its association with chl and other tyrosine phosphorylated proteins.
Although some surface receptor proteins have been shown to associate with PI 3-K after ligand stimulation,"'." we could detect neither increased PI 3-K activity nor the presence of tyrosine phosphorylated proteins in anti-CD38 antibody immunoprecipitates, even under mild detergent conditions (ie, using a lysis buffer containing 0.1% NP-40 or 0.5% digitonin; data not shown). Thus, the molecular links between CD38 and PI 3-K are still unknown. -121 Effect of PI 3-K inhibitors on CD38-induced growth slippression. To test whether activation of PI 3-K was related to growth suppression after CD38 ligation, we took advantage of two compounds, wortmannin and LY294002, which preferentially inhibit PI 3-K both in vitro and in We previously showed that CD38-mediated suppression of cell growth can be seen only in cultures supported by stroma or stroma-derived cytokines.' Thus, their effects were tested in stroma-supported 4-day cultures of immature I3 cells (380, REH, and RS4; 1 1 ) exposed to anti-CD38 antibody. A single addition of wortmannin (100 nmol/L) or LY294002 (2 pmol/ L) at the beginning of the cultures inhibited CD38-induced growth suppression in the three cell lines (Table I) . Similar REH RS4;11 Fig 4 . Ligation of CD38 increases PI 3-K activity in anti-cbl immunoprecipitates. 380, REH, and RS4; 11 were incubated with antLCD38 antibody or control lgGl for 5 minutes. Cell lysates were immunoprecipitated with anti-cblantibody and PI 3-K activity in the immunoprecipitates was measured as described in the Materials and Methods. Autoradiograms of thin-layer chromatography plates after separation of the resulting phosphatidylinositol 3-phosphate are shown.
results were obtained when TI6 was replaced by another antLCD38 antibody (IB4 of IgG2 class; gift of Dr F. Malavas, University of Ancona. Italy; data not shown). CD38 surface expression remained unchanged when measured after 30 minutes and 24 hours of incubation of 380 and REH cells with the inhibitors (data not shown). Thus, the effect of PI 3-K inhibitors was not due to downregulation of CD38 expression.
In dose-response experiments, the effects of wortmannin were maximal at 100 nmoVL. At this concentration, recovery of viable cells was similar (>80%) to that of control cultures with 0.05% DMSO, whereas higher concentrations were markedly cytotoxic (data not shown). The optimal concentration of LY294002 was 2 pnol/L, because higher concentrations were also cytotoxic.
In our experiments, a single addition of wortmannin to cultures effectively rescued immature B cells from CD38-mediated suppression. Wortmannin is known to be unstable, and its anti-PI 3-K effect may weaken during culture.'" In time-course experiments with the 380 cell line, wortmannin (100 nmol/L) rescued cells exposed to anti-CD38 only when added to cultures within 12 hours of CD38 ligation (data not shown). These results suggest that early activation of PI 3-K after CD38 ligation is critical for subsequent growth suppression.
The above experiments were performed with immature B cells in coculture with stroma. To determine whether the effect of wortmannin on CD38-induced growth suppression could extend to stroma-free cultures, 380 cells were incubated in the presence of three stroma-derived cytokines-IL-3 (10 ng/mL), IL-7 (25 ng/mL), and SCF (20 ng/mL)-culture conditions that also permit CD38-mediated suppression of cell growth.' After 4 days of culture, there was a marked decrease in cell recovery in the presence of anti-CD38, and the addition of wortmannin to the cultures reversed this suppressive effect (Fig 5) . Similar results were obtained when only IL-3 was used (data not shown). Thus, wortmannin's reversal of CD38-mediated growth suppression reflects its direct effect on immature lymphoid cells, rather than an indirect effect on stroma elements.
Finally, we determined whether the rescuing effects of PI 3-K inhibitors extended to cultures of normal B-cell progenitors and leukemic lymphoblasts from patients. In four experiments with purified normal bone marrow B cells, CD38 ligation induced marked loss of CD19' sIg-B-cell precursors, an effect that was antagonized by adding 1 0 0 nmol/L wortmannin to the cultures (Table 1 and Fig 6) . Wortmannin and LY294002 had similar effects on CD38+ ALL cells from patients ( Table 1) .
Inhibition of PI 3-K activity by wortmannin and LY294002. In the next set of experiments, we measured the concentrations of wortmannin and LY294002 needed to inhibit PI 3-K activity, for comparison with the concentrations needed to rescue cell growth in the same cells. At 100 nmol/L, wortmannin inhibited virtually all detectable PI 3-K activity in immunoprecipitates produced with antibody to PI 3-K p85 in 380 cells, whereas 2 ,umol/L LY294002 inhibited PI 3-K activity by approximately 50% (Fig 7A) . The addition of 100 nmol/L wortmannin to intact 380 and REH cells also significantly inhibited the activity of PI 3-K immunoprecipitated by antiphosphotyrosine antibody after CD38 ligation (P < .02; Fig 7B) , but no significant differences were detectable after incubation with 2 ,umol/L LY294002 The PI 3-K activity precipitated by an antiphosphotyrosine antibody was measured as described in the Materials and Methods. Bars (mean 2 SD of triplicate tests) represent the ratio of PI 3-K activity in CD38-stimulated cells to that in unstimulated cells.
( Fig 7B) . This finding was not unexpected, because binding of LY294002 to PI 3-K is readily reversible and is unlikely to survive immunoprecipitation. 16. 31 We also determined whether wortmannin or LY294002 influenced protein tyrosine phosphorylation induced by CD38 dimerization. As shown in Fig 8, CD38 ligation in 380 and REH cells induced rapid tyrosine phosphorylation of several intracellular proteins, and PI 3-K was present in antiphosphotyrosine immunoprecipitates. Preincubation of cells with 100 nmol/L wortmannin or 2 pmol/L, LY294002 did not inhibit CD38-induced protein tyrosine phosphorylation, and the amount of PI 3-K p85 protein coprecipitated with tyrosine-phosphorylated proteins was not affected by preincubation with the inhibitors. These data collectively indicate that wortmannin and LY294002 rescue immature B cells from CD38-mediated growth suppression by inhibiting PI 3-K rather than protein tyrosine kinase activity.
Rapamycin does not rescue immature B cells from CD38-mediated growth suppression. It has been reported that wortmannin and LY294002 can also block p70 S6-kinase activity caused by platelet-derived growth factor and insulin s t i m~l a t i o n .~~.~~ To determine whether p70 S6-kinase was involved in the CD38-mediated suppression of cell growth, we used rapamycin at a concentration (10 ng/mL) that abrogates p70 S6-kinase a~t i v i t y .~~,~~ In 380 and REH cells, rapamycin decreased cell recovery after 4 days of culture on stroma. Mean cell recovery rates were 3 1 % in 380 and 34% in REH cells (in quadruplicate measurements), as compared with control cultures without rapamycin. Lower recovery rates were attributed to cell cycle arrest, a known effect of rapamycin, because cell viability remained greater than 90% (data not shown). In parallel cultures, mean cell recovery in the presence of antLCD38 was 17% in 380 cells and 31% in REH cells. The addition of rapamycin to cultures containing anti-CD38 did not improve cell recovery. On the contrary, cell recovery was 7% in 380 and 14% in REH in cultures containing both anti-CD38 and rapamycin. Thus, the rescuing effects of wortmannin and LY294002 are unlikely to be due to p70 S6-kinase inhibition.
DISCUSSION
Normal and malignant cells have signaling pathways that can arrest the cell cycle and trigger programmed cell death. 35 In immature B cells, one such regulatory pathway is initiated by CD38 dimerization.' In beginning to elucidate the biochemical changes accompanying CD38-mediated growth suppression, we had previously shown that CD38 dimerization rapidly activates protein tyrosine kinase-dependent phosphorylation, including that of syk and PLCy.' In the present study, we have identified cbl and PI 3-K as key components of this signaling pathway and established a connection between biochemical events and cellular response. chl is a 906 amino acid protein that is found in the cytosol and cytoskeletal compartments of early B-lineage and myeloid cells and in nonhematopoietic chl lacks kinase activity but contains several proline-rich motifs and multiple potential tyrosine phosphorylation sites that might mediate its interaction with protein displaying SH3 and SH2 domain~..".'~ Tyrosine phosphorylation of chl occurs after the engagement of a variety of cell surface receptors, and its binding to proteins involved in signal transduction, including Src-family kinases, htk, ah/, nck, grh2, PLCy, and PI 3-K, has been ~h o w n .~' )~~~~. '~ After Fcy receptor engagement, chl also binds to syk." However, under conditions that preserved cbl/PI 3-K association, we could not detect cbllsyk association in REH and RS4:ll cells after CD38 ligation (data not shown). Tyrosine phosphorylation of chl may also be accompanied by its subcellular transl~cation.~~ Thus, chl could promote the formation of transient signaling complexes containing different proteins that may regulate cellular functions by promoting localized increases in enzymatic activity of the associated proteins." Our results indicate that the ccllular consequcnces of chl activation includc cell cyclc arrest and apoptosis. Involvement of cbl may be a common feature of CD38-mediated signal transduction, because Kontani et al'9 have also recently found chl tyrosine phosphorylation after engagement of CD38 in retinoic acid-treated HL60 myeloid cells. functions.'".l3 Our observation that PI 3-K activation results in inhibition of proliferation and induction of apoptosis contrasts with the involvement of this molecule in promoting cell growth observed in other cell models."'." However, of note, Beckwith et al'" recently reported that PI 3-K activity is required for the anti-Ig-mediated growth inhibition of a B-lymphoma cell line. The biochemical events leading to the diverse cellular functions of PI 3-K activity remain to be elucidated, although it has been recently suggested that these could result from specific D3 phosphoinositides binding to distinct SH2 domain^.^' Because our initial experiments with PI 3-K inhibitors used stroma-supported cultures of immature B cells, the effects of wortmannin and LY294002 might have reflected suppression of the stroma stimulus, rather than a direct effect on immature B cells. This possibility was proved untrue by the ability of wortmannin to rescue cells from the suppressive effects of CD38 ligation in cultures in which stroma was replaced by IL-3, IL-7, and SCF. Notably, similar results were seen with IL-3 alone, but we failed to detect increased PI 3-K activity in antiphosphotyrosine immunoprecipitates from 380 cells exposed to IL-3 (data not shown). Thus, we believe that changes on PI 3-K activity mediated by CD38 ligation, rather than by cytokines or contact with stroma, are central to the resulting growth suppression. PI 3-K inhibitors did not completely rescue cells from CD38-mediated inhibition. Although this could be due to the instability of the compounds in culture, we cannot rule out that PI 3-K-independent signaling could also bc involved.
The human CD38 is a type I1 transmembrane protein with a short intracytoplasmic domain that does not contain antigen recognition activation motifs (ARAM) or tyrosine residues.' Thus, it is likely that CD38-mediated signaling involves activation of other membrane-associated components. However, these have not yet been identified. Funaro et al" found coFor personal use only. on August 30, 2017 . by guest www.bloodjournal.org From capping of CD38 with surface Ig and CD19 in mature B cells, and the latter may be involved in CD38-mediated signaling in sIg-immature B cells. Although CD38 expression in immature B cells is not apparently modulated after incubation with specific antibodies, a similar interaction needs to be tested in these cells. However, we have so far been unable to detect CD38-associated proteins using a variety of lysing conditions (data not shown).
In conclusion, we have shown that CD38-mediated signal transduction in immature lymphoid cells involves tyrosine phosphorylation of cbl and its association with PI 3-K; activation of PI 3-K results in cell cycle arrest and apoptosis. CD38-mediated signal transduction may be crucial in the homeostatic control of lymphopoiesis. Importantly, this control mechanism in normal B-cell progenitors remains intact in their leukemic counterparts, offering a potentially effective avenue of therapeutic inter~ention.~~ Agonistic antibodies that activate CD38-derived growth inhibitory signals could be exploited for treating leukemia and without the need for toxin conjugation. Importantly, virtually all cases of ALL express CD38,43 and CD38 dimerization is highly effective in suppressing leukemic cell growth in vitro' and in SCID mice engrafted with human ALL cells (K.F. Bradstock, University of Sydney, Sydney, Australia, personal communication, October 1995). Humanized anti-CD38 antibodies for in vivo immunotherapy have already been engineered,44 based on the consideration that CD38 is only weakly expressed or absent in primitive multipotent hematopoietic ~e l l s .~~.~~
